Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

708
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
708
Stereotype Content Model02:16

Stereotype Content Model

15.7K
The Stereotype Content Model (SCM) was first proposed by Susan Fiske and her colleagues (Fiske, Cuddy, Glick & Xu, 2002; see also Fiske, 2012 and Fiske, 2017). The SCM specifies that when someone encounters a new group, they will stereotype them based on two metrics: warmth—or that group’s perceived intent, and how likely they are to provide help or inflict harm—and competence—or their ability to carry out that objective. Depending on the warmth-competence...
15.7K
Automatic Processing and Automatic Social Behavior01:28

Automatic Processing and Automatic Social Behavior

357
Automatic processing refers to the cognitive operations that occur without conscious intent or awareness, playing a fundamental role in shaping social cognition and behavior. These processes enable individuals to navigate complex social environments efficiently by relying on mental shortcuts and pre-existing knowledge structures known as schemas. One of the most influential mechanisms underlying automatic processing is priming, which subtly activates mental representations through exposure to...
357
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

1.2K
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
1.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

2.0K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Validated Measures of Agitation in Neurocognitive Disorders: A Systematic Review of 41 Scales and Their Alignment With International Psychogeriatric Association Criteria.

The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry·2026
Same author

Expert consensus on the use of trazodone in patients with major depressive disorder: results from a European Delphi panel.

European psychiatry : the journal of the Association of European Psychiatrists·2026
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Elucidating the Role of <i>KRAS</i>, <i>NRAS</i>, and <i>BRAF</i> Mutations and Microsatellite Instability in Colorectal Cancer via Next-Generation Sequencing.

Cancers·2025
Same author

[Cross-cultural validation of the Yale Food Addiction Scale for Children (YFAS-c) into the Spanish language to assess food addiction in the pediatric population].

Spanish journal of psychiatry and mental health·2024
Same author

Clinical decision-making before discharge in hospitalized persons with schizophrenia: a Spanish Delphi expert consensus.

Frontiers in psychiatry·2024

Related Experiment Video

Updated: Apr 3, 2026

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

1.7K

Social robots in advanced dementia.

Meritxell Valentí Soler1, Luis Agüera-Ortiz2, Javier Olazarán Rodríguez3

  • 1Research Unit, CIEN Foundation, Carlos III Institute of Health, Alzheimer Center Reina Sofía Foundation Madrid, Spain.

Frontiers in Aging Neuroscience
|September 22, 2015
PubMed
Summary

Robot companions like PARO and NAO showed potential in dementia therapy, improving apathy and quality of life in nursing home patients. Further research is needed to fully understand their impact on cognition and behavior.

Keywords:
Alzheimer diseaseanimal assisted therapyapathydementiahuman-robot interactionroboticstechnologytherapy

More Related Videos

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
07:14

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

Published on: December 23, 2025

766

Related Experiment Videos

Last Updated: Apr 3, 2026

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes
04:49

Author Spotlight: Enhancing Post-Stroke Upper Limb Rehabilitation with Robotic Technologies for Improved Motor Recovery and Functional Outcomes

Published on: September 6, 2024

1.7K
Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models
07:14

Virtual Agent for Real-Time Motivational Interviewing by Integrating Adaptive Nonverbal Behavior and Language Models

Published on: December 23, 2025

766

Area of Science:

  • Gerontology
  • Robotics in Healthcare
  • Dementia Care

Background:

  • Dementia care settings often explore innovative therapeutic interventions.
  • Robots and animals have been investigated as supplementary tools in patient care.
  • Understanding the efficacy of different therapeutic modalities is crucial for improving patient outcomes.

Purpose of the Study:

  • To pilot the application of humanoid (NAO) and pet (PARO) robots, alongside a real animal (DOG), in therapy for dementia patients.
  • To compare the effects of these interventions in a nursing home and a day care center setting.
  • To evaluate changes in cognitive function, neuropsychiatric symptoms, apathy, and quality of life.

Main Methods:

  • A pilot study involving parallel therapeutic arms in a nursing home (CONTROL, PARO, NAO, DOG) and a combined approach in a day care center (NAO, PARO).
  • Therapy sessions were conducted twice weekly for three months.
  • Blind raters assessed patients at baseline and follow-up using validated scales (GDS, sMMSE, MMSE, NPI, APADEM-NH, AI, QUALID).

Main Results:

  • In the nursing home, robot interventions improved apathy scores. The NAO group showed a decline in MMSE scores, but not sMMSE. The PARO group demonstrated increased Quality of Life Scale (QUALID) scores in Phase 2.
  • In the day care center, Phase 1 (NAO) showed improvements in NPI irritability and total scores.
  • No significant differences were observed in Phase 2 at the day care center.

Conclusions:

  • Robot-assisted therapy, particularly with PARO, shows promise in improving apathy and quality of life for dementia patients in nursing homes.
  • The impact on cognitive function requires further investigation, as observed with the NAO robot.
  • Interventions in day care settings yielded mixed results, suggesting context-dependent efficacy.